Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization

Cellular and Molecular Life Sciences

Volumn 55, Issue 8-9, 1999, Pages 1015-1028

  Boucher, J L ^a   Moali, C ^a   Tenu, J P ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

Author keywords

Arginase; L arginine; N( ) hydroxy L arginine; Nitric oxide; Nitric oxide synthase; Peroxynitrite; Superoxide radical; Urea cycle

Indexed keywords

ARGINASE; ARGININE; CALMODULIN; CITRULLINE; CYTOCHROME P450; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TETRAHYDROBIOPTERIN;

AMINO ACID METABOLISM; ANIMAL CELL; BIOSYNTHESIS; BLOOD PRESSURE REGULATION; ENZYME ACTIVE SITE; ENZYME MECHANISM; ENZYME REGULATION; ENZYME STABILITY; ENZYME STRUCTURE; HUMAN; HUMAN CELL; MEDIATOR; NEUROTRANSMISSION; NONHUMAN; OXIDATION; PROTEIN DOMAIN; REVIEW;

EID: 0032787622     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050352     Document Type: Review

References (123)

1. 1 (1992) Metabolic, physiological and nutritional importance of urginine In: Guanidino Compounds in Biology and Medicine, pp. 61-144, DeDeyn P. P., Marescau B., Stalon V. and Qureshi I. A. (eds), Libbey, London
2. 2 Wu G. and Morris S. M. (1998) Arginine metabolism: nitric oxide and beyond. Biochem. J. 336: 1-17
3. 3 Ignarro L. and Murad F. (eds) (1995) Nitric Oxide: Biochemistry, Molecular Biology, and Therapeutic Implications, Academic Press, San Diego
4. 4 Jenkinson C. P., Grody W. W. and Cederbaum S. D. (1997) Comparative properties of arginases. Comp. Biochem. Physiol. Biochem. Mol. Biol. 114B: 107-132
5. 5 Feldman P. L., Griffith O. W. and Stuehr D. J. (1993) The surprising life of nitric oxide. Chem. Eng. News: 26-38
6. 6 Kerwin J. F. and Heller M. (1994) The arginine-nitric oxide pathway: a target for new drugs. Med. Res. Rev. 14: 23-74
7. 7 Kerwin J. F., Lancaster J. R. and Feldman P, L. (1995) Nitric oxide: a new paradigm for second messengers. J. Med. Chem. 38: 4343-4362
8. 8 Nathan C. and Xie Q. W. (1994) Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269: 13725-13728
9. 9 Moncada S. and Higgs E. A. (1995) Molecular mechanisms and therapeutic strategics related to nitric oxide. FASEB J. 9: 13619-13630
10. w-Hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266: 6259-6263
11. 11 Knowles R. G. and Moncada S. (1994) Nitric oxide synthases in mammals. Biochem. J. 298: 249-258
12. 12 Förstermann U., Closs E. I., Pollock J. S., Nakane M., Schwarz P., Gath I. et al. (1994) Nitric oxide synthase isozymes. characterization, purification, molecular cloning, and functions. Hypertension 23: 1121-1131
13. 13 Förstermann U. and Kleinert H. (1995) Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedebergs Arch. Pharmacol. 352: 351-364
14. 14 Förstermann U., Boissel J. P. and Kleinert H. (1998) Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 12: 773-790
15. 15 Bredt D. S., Hwang P. M., Glatt C. E., Lowenstein C., Reed R. R. and Snyder S. H. (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351: 714-718
16. 16 While K. A. and Marletta M. A. (1992) Nitrit oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 31: 6627-6631
17. 17 Stuehr D. J. and Ikeda-Saito M. (1992) Spectral characterization of brain and macrophage nitric oxide synthases: cytochrome P-450-like hemeproteins that contain a flavin semiquinone radical. J. Biol. Chem. 267: 20547-20550
18. 18 McMillan K., Bredt D. S., Hirsch D. J., Snytler S. H., Clark J. E. and Masters B. S. S. (1992) Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc. Natl. Acad. Sci. USA 89: 11141-11145
19. 19 Klatt P., Schmidt K. and Mayer B. (1992) Brain nitric oxide synthase is a haemoprotein. Biochem. J. 288: 15-17
20. 20 Masters B. S. S., McMillan K., Sheta E. A., Nishimura J. S., Roman L. J. and Martasek P. (1996) Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: structure studies of a cysteine thiolate-liganded heme protein that hydroxylates L-arginine to produce NO as a cellular signal. FASEB J. 10: 552-558
21. 21 Stuehr D. J. (1997) Structure-function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol. 37: 339-359
22. 22 McMillan K. and Masters B. S. S. (1995) Prokaryotic expression of the heme-and flavin-binding domains of rat neuronal nitric oxide synthase as distinct polypeptides: identification of the heme-binding proximal thiolate ligand as cysteine-415. Biochemistry 34: 3686-3693
23. 23 Sari M. A., Booker S., Jaouen M., Vadon S., Boucher J. L., Pompon D. et al. (1996) Expression in yeast and purification of functional macrophage nitric oxide synthase: evidence for cysteine-194 as iron proximal ligand. Biochemistry 35: 7204-7213
24. 24 Chen P. F., Tsai A. L. and Wu K. K. (1994) Cysteine 184 of endothelial nitric oxide synthase is involved in heme coordination and catalytic activity. J. Biol. Chem. 269: 25062-25066
25. 25 Baek K. J., Thiel B. A., Lucas S. and Stuehr D. J. (1993) Macrophage nitric oxide synthase subunits: purification, characterisation and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J. Biol. Chem. 268: 21120-21129
26. 26 Matsuoka A., Stuehr D. J., Olson J. S., Clark P. and Ikeda-Saito M. (1994) L-Arginine and calmodulin regulation of the heme iron reactivity in neuronal nitric oxide synthase. J. Biol. Chem. 269: 20335-20339
27. 27 Abu-Soud H. M., Yoho L. L and Stuehr D. J. (1994) Calmodulin controls neuronal nitric oxide synthase by a dual mechanism: activation of intra-and interdomain electron transfer. J. Biol. Chem. 269: 32047-32050
28. 28 Ghosh D. K. and Stuehr D. J, (1995) Macrophage NO synthase: characterization of isolated oxygenase and reduclase domains reveals a head-to-head subunit interaction. Biochemistry 34: 801-807
29. 29 Siddhanta U., Presta A., Fan B., Wolan D., Rousseau D. L. and Stuehr D. J. (1998) Domain swapping in inducible nitric oxide synthase: electron transfer occurs between flavin and heme groups located on adjacent subunit in the dimer. J. Biol. Chem. 273: 18950-18958
30. 30 Abu-Soud H. M., Loftus M. and Stuehr D. J. (1995) Subunit dissociation and unfolding of macrophage NO synthase: relationship between enzyme structure, prosthetic group binding and catalytic function. Biochemistry 34: 11167-11175
31. 31 Mayer B., Wu C., Gorren A. C. F., Pfeiffer S., Schmidt K., Clark P. et al. (1997) Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: heme-spin shift and dimer stabilization by the potent potent antagonist 4-amino-tetrahydrobiopterin. Biochemistry 36: 8422-8427
32. 32 Presta A., Siddhanta U., Wu C., Sennequier N., Huang L., Abu-Soud H. M. et al. (1998) Comparative functioning of dihydro-and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry 37: 298-310
33. 33 Klan P., Pfeiffer S., List B, M., Lehner D., Glatter O., Bächinger H. P. et al. (1996) Characterization of heme-defitient neuronal nitric oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. J. Biol. Chem. 271: 7336-7342
34. 34 Gorren A. C. F., List B. M., Schrammel A., Pitters E., Hemmens B., Werner E. R. et al. (1996) Tetrahydrobiopterin-free neuronal nitric oxide synthase: evidence for two identical highly anticooperative pteridine binding sites. Biochemistry 35: 16735-16745
35. 35 Hemmens B., Gorren A. C. F., Schmidt K., Werner E. R. and Mayer B. (1998) Haem insertion, dimerization and reactivation of haem-free rat neuronal nitric oxide synthase. Biochem. J. 332: 337-342
36. 36 Scheele J. S., Kharitonov V. G., Martasek P., Roman L. J., Sharma V. S., Masters B. S. S. et al. (1997) Kinetics of CO ligation with nitric oxide synthase by flash photolysis and stopped-flow spectrophotometry. J. Biol. Chem. 272: 12523-12528
37. 37 Abu-Soud H. M., Wu C., Ghosh D. K. and Stuehr D. J. (1998) Stopped-flow analysis of CO and NO binding to inducible nitric oxide synthase. Biochemistry 37: 3777-3786
38. 38 Wang J., Rousseau D. L., Abu-Soud H. M. and Stuehr D. J. (1994) Heme coordination of NO in NO synthase. Proc. Natl. Acad. Sci. USA 91: 10512-10516
39. 39 Abu-Soud H. M., Gachhui R., Raushel F. M. and Stuehr D. J. (1997) The ferrous-dioxy complex of neuronal nitric oxide synthase: divergent effects of L-arginine and tetrahydrobiopterin on its stability. J. Biol. Chem. 272: 17349-17353
40. 40 Renodon A., Boucher J. L., Wu C., Gacchui R., Sari M. A., Mansuy D. et al. (1998) Formation of nitric oxide synthaseiron(II) nitrosoalkane complexes: severe restriction of access to the iron(II) site in the presence of tetrahydrobiopterin. Biochemistry 37: 6367-6374
41. 41 Chabin R. M., McCauley E., Calaycay J. R., Kelly T. M., MacNaul K. L., Wolfe G. C. et al. (1996) Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole. Biochemistry 35: 9567-9575
42. 42 Counts-Gerber N., Rodriguez-Crespo I., Nishida C. R. and Ortiz de Montellano P. R. (1997) Active site topologies and cofactor-mediated conformational changes of nitric oxide synthases. J. Biol. Chem. 272: 6285-6290
43. 43 Presta A., Weber-Main A. M., Stankovich M. T. and Stuehr D. J. (1998) Comparative effects of substrates and pterin cofactor on the heme midpoint potential in inducible and neuronal nitric oxide synthases. J. Am. Chem. Soc. 120: 9460-9465
44. 44 Crane B. R., Arvai A. S., Gachhui R., Wu C., Ghosh D. K., Getzoff E. D. et al. (1997) The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 278: 425-431
45. 45 Crane B. R., Arvai A. S., Ghosh D. K., Wu C., Getzoff E. D., Stuehr D. J. et al. (1998) Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279: 2121-2126
46. 46 Chénais B., Yapo A., Lepoivre M. and Tenu J. P. (1991) High-performance liquid chromatographic analysis of the unusual pathway of oxidation of L-arginine to citrulline and nitric oxide in mammalian cells. J. Chromatogr. 539: 433-441
47. 47 Buga G. M., Singh R., Pervin S., Rogers N. E., Schmilz D. A., Jenkinson C. P. et al. (1996) Arginase activity in en-dothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. Am. J. Physiol. 271: H1988-H1998
48. 48 Ortiz de Montellano P. R. (ed.) (1995) Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd ed., pp. 245 304, Plenum, New York
49. 49 Rusche K. M., Spiering M. M. and Marletta M. A. (1998) Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase. Biochemistry 37: 15503-15512
50. w-hydroxy-nor-L-arginine. Biochemistry 37: 10453-10460
51. w-hydroxy-L-arginine to citrulline and nitric oxide. J. Biol. Chem. 269: 17776-17779
52. 52 Babu B. R. and Griffith O. W. (1998) Design of isoform-selective inhibitors of nitric oxide synthase. Curr. Opin. Chem. Biol. 2; 491-500
53. 53 Miller R. T., Martasek P., Roman L. J., Nishimura J. S. and Masters B. S. S. (1997) Involvement of the reductase domain of neuronal nitric oxide synthase in Superoxide anion production. Biochemistry 36: 15277-15284
54. 54 Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B. S. S., Karoui H. et al. (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofaclors. Proc. Natl. Acad. Sci. USA 95: 9220-9225
55. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J. Biol. Chem. 273: 25804-25808
56. 56 Xia Y., Roman L. J., Masters B. S. S. and Zweier J. L. (1998) Inducible nitric oxide synthase generates Superoxide from the reductase domain. J. Biol. Chem. 273: 22635-22639
57. G-hydroxy-L-arginine by nitric oxide synthase. Biochemistry 34: 1930-1941
58. 58 Ghosh D. K., Abu-Soud H. M. and Stuehr D. J. (1995) Reconstitution of the second step in NO synthesis using the isolated oxygenase and reductase domains of macrophage NO synthase. Biochemistry 34: 11316-11320
59. G-hydroxy-L-arginine and hydrogen peroxide by neuronal nitric oxide synthase: implications for mechanism. Biochemistry 36: 14465-14473
60. 60 Geller D. A., Lowenstein C. J., Shapiro R. A., Nussler A. K., DiSilvio M., Wang S. C. et al. (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocyles. Proc. Natl. Acad. Sci. USA 90: 3491-3495
61. 61 Ding M, Zhang M., Wong J. L., Rogers N. E., Ignarro L. J. and Voskuhl R. R. (1998) Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160: 2560-2564
62. 62 Stuehr D. J., Fesahun O. A., Kwon N. S., Gross S. S., Gonzalez J. A., Levi R. et al. (1991) Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 5: 98-103
63. 63 Abu-Soud H. M., Wang J., Rousseau D. L., Fukuto J. M., Ignarro L. J. and Stuehr D. J. (1995) Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J. Biol. Chem. 270: 22997-23006
64. 64 Hühmer A. F. R., Nishida C. R., Ortiz de Montellano P. R. and Schöneich C. (1997) Inactivation of the inducible nitric oxide synthase by peroxynitrite. Chem. Res. Toxicol. 10: 618-626
65. 65 Renodon A., Boucher J. L., Sari M. A., Delaforge M., Ouazzani J. and Mansuy D. (1997) Strong inhibition of neuronal nitric oxide synthase by the calmodulin antagonist and anti-estrogen drug tamoxifen. Biochem. Pharmacol. 54: 1109-1114
66. 66 Zhang M. and Vogel H. J. (1994) Characterization of the calmodulin-binding domain of rat cerebellar nitric oxide synthase. J. Biol. Chem. 269: 981-985
67. 67 Salerno J. C., Harris D. E., Irizarry K., Patel B., Morales A. J., Smith S. M. E. et al. (1997) An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J. Biol. Chem. 272: 29769-29777
68. 68 Hibbs J. B. J., Vavrin Z. and Taintor R. R. (1987) L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138: 550-565
69. G-cyclopropyl-L-arginine: two novel inhibitors of macrophage nitric oxide synthase. J. Med. Chem. 35: 1137-1144
70. w-propyl-L-arginine. J. Med. Chem. 40: 3869-3870
71. 71 McCall T. B., Feelisch M., Palmer R. M. J. and Moncada S. (1991) Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br. J. Pharmacol. 102: 234-238
72. G-(I-Iminoethyl) lysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. 37: 3886-3888
73. 73 Frey C., Narayanan K., McMillan K., Spack L., Gross S. S., Masters B. S. S. et al. (1994) L-Thiocitrulline: a stereospecific, heme-binding inhibitor of nitric oxide synthases. J. Biol. Chem. 269: 26083-26091
74. 74 Furfine E. S., Harmon M. F., Paith J. E., Kmowles R. G., Salter M., Kiff R. J. et al. (1994) Potent and selective inhibition of human nitric oxide synthases; selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiodtrulline. J. Biol. Chem. 269: 26677-26683
75. 75 Narayanan K., Spack L., McMillan K., Kilbourn R. C., Hayward M. A., Masters B. S. S. et al. (1995) S-Alkyl-L-thiocitrullines: potent stereoseleclive inhibitors of nitric oxide synthase with strong presser activity in vivo. J. Biol. Chem. 270: 11103-11110
76. 76 Abu-Soud H. M., Feldman P. L., Clark P. and Stuehr D. J. (1994) Electron transfer in the nitric oxide synthases: characterization of L-arginine analogs that block heme iron reduction. J. Biol. Chem. 269; 32318-32326
77. 77 Sennequier N. and Stuehr D. J. (1996) Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase. Biochemistry 35: 5883-5892
78. G(I-Iminoethyl) lysine. Biochemistry 37: 4844-4852
79. 79 Garvey E. P., Oplinger J. A., Tanoury G. J., Sherman P. A., Fowler M., Marshall S. et al. (1994) Potent and selective inhibition of human nitric oxide synthases: inhibition by non-amino acid isothioureas. J. Biol. Chem. 269: 26669-26676
80. 80 Szabo C., Ferrer-Sueta G., Zingarelli B., Southan G. J., Salzman A. L. and Radi R. (1997) Mercaptoethylguanidine and guanidine inhibitors of nitric oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J. Biol. Chem. 272: 9030-9036
81. 81 Shearer B. G., Lee S., Oplinger J. A., Frick L. W., Garvey E. P. and Furfine E. S. (1997) Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity. J. Med. Chem. 40: 1901-1905
82. 82 Garvey E. P., Oplinger J. A., Furtine E. S., Kiff R. J., Laszlo F., Whittle B. J. R. et al. (1997) 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo. J. Biol. Chem. 272: 4959-4963
83. 83 Collins J. L., Shearer B. G., Oplinger J. A., Lee., Garvey E. P., Salter M. et al. (1998) N-phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity. J. Med. Chem. 41: 2858-2871
84. 84 Webber R. K., Metz S., Moore W. M., Connor J. R., Currie M. G., Fok K. F. et al. (1998) Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms. J. Med. Chem. 41: 96-101
85. 85 Hansen D. W., Peterson K. B., Trivedi M., Kramer S. W., Webber R. K., Tjoeng F. S. et al. (1998) 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase. J. Med. Chem. 41: 1361-1366
86. 86 Hagen T. J., Bergmanis A. A., Kramer S. W., Fok K. F., Schmelzer A. E., Pitzele B. S. et al. (1998) 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase. J. Med. Chem. 41: 3675-3683
87. 87 Southan G. J., Gauld D., Lubeskie A., Zingarelli B., Cuzzocrea S., Salzman A. L. et al. (1997) Inhibition of nitric oxide synthase with pyrazole-1-carboxamidine and related compounds. Biochem. Pharmacol. 54: 409-417
88. 88 Berka V., Palmer G., Chen P. F. and Tsai A. L. (1998) Effects of various imidazole ligands on heme conformation in endothelial nitric oxide synthase. Biochemistry 37: 6136-6144
89. 89 Handy R. L. C, Wallace P., Gaffen Z. A., Whitehead K. J. and Moore P. K. (1995) The antinociceptive effect of 1-(2-trifluoromethylplienyl) imidazole (TRIM): a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br. J. Pharmacol. 116: 2349-2350
90. 90 Bogle R. G., Whitley G. J., Soo S.C., Johnstone A. P. and Vallance P. (1994) effect of anti-fungal imidazoles on mRNA levels and enzyme activity of inducible nitric oxide synthase. Br. J. Pharmacol. 111: 1257-1261
91. 91 Wolff D. J. and Gribin B. J. (1994) The inhibition of the constitutive and inducible nitric oxide synthase isoforms by indazole agents. Arch. Biochem. Biophys. 311: 300-306
92. 92 Kanyo Z. F., Scolnick L. R., Ash D. E. and Christianson D. W. (1996) Structure of a unique binuclear manganese cluster in arginase. Nature 383: 554-557
93. 93 Spector E. B., Jenkinson C. P., Grigor M. R., Kern R. M. and Cederbaum S. D. (1994) Subcellular localization and differential antibody specificity of arginase in tissue culture and whole animal. Int. J. Dev. Neurosci. 12: 337-342
94. 94 Gotoh T., Sonoki T., Nagasaki A., Terada K., Takiguchi M. and Mori M. (1996) Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett. 395: 119-122
95. 95 Morris S. M., Bhamidipati D. and Kepka-Lenhart D. (1997) Human type II arginasc: sequence analysis and tissue-specific expression. Gene 193: 157-161
96. 96 Cook H. T., Jansen A., Lewis S., Largen P., O'Donnell M., Reaveley D. et al. (1994) Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase. Am. J. Physiol. 267: F646-F653
97. 97 Mills C. D., Shearer J., Evans R. and Caldwell M. D. (1992) Macrophage arginine metabolism and the inhibition or stimulation of cancer. J. Immunol. 149: 2709-2714
98. 98 Hrabak A., Idei M. and Temesi A. (1994) Arginine supply for nitric oxide synthesis and arginase is mainly exogenous in clicited murine and rat macrophages. Life Sci. 55: 797-805
99. 99 Chang C. I., Liao J. C. and Kuo L. (1998) Arginase modulates nitric oxide production in activated macrophages. Am. J. Physiol. 274: H342-H348
100. G-hydroxy-L-arginine: implication for the regulation of nitric oxide biosynthesis by arginase. Biochem. Biophys. Res. Commun. 202: 174-180
101. 101 Boucher J. L., Custot J., Vadon S., Delaforge M., Lepoivre M., Tenu J. P. et al. (1994) Nw-Hydroxy-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem. Biophys. Res. Commun. 203; 1614-1621
102. 102 Hey C., Wessler I. and Racké K. (1995) Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity. Naunyn-Schmiedebergs Arch. Pharmacol. 351: 651-659
103. G-hydroxy-L-arginine in alveolar macrophages: implication for the utilisation of L-arginine for nitric oxide synthesis. FEBS Lett. 359: 251-254
104. w-hydroxy-nor-L-arginine: a high-affinity inhibitor of arginase well adapted to bind to its manganese cluster. J. Am. Chem. Soc. 119: 4086-4087
105. w-hydroxy-D,L-indospicine: effects on L-arginine utilization by nitric oxide synthase. Br. J. Pharmacol. 121: 395-400
106. 106 Mori M., Gotoh T., Nagasaki A., Takiguchi M. and Sonoki T. (1998) Regulation of the urea cycle enzymes genes in nitric oxide synthesis. J. Inherited Metab. Dis. 21: 59-71
107. 107 Sonoki T., Nagasaki A., Gotoh T., Takiguchi M., Takeya M., Matsuzaki H. et al. (1997) Conduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J. Biol. Chem. 272: 3689-3693
108. 108 Louis C. A., Reichner J. S., Henry W. L., Mastrofrancesco B., Gotoh Y., Mori M. et al. (1998) Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am. J. Physiol. 274: R775-R782
109. 109 Wang W. W., Jenkinson C. P., Griscavage J. M., Kern R, M., Arabolos N. S., Byrns R. E. et al. (1995) Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Res. Commun. 210: 1009-1016
110. 110 Corraliza I. M., Soler G., Eichmann K. and Modolell M. (1995) Arginuse induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 206: 667-673
111. 111 Cunningham J. M., Mabley J. G. and Green I. C. (1997) Interleukin 1-beta-mediated inhibition of arginase in RINm5F cells. Cytokine 9: 570-576
112. 112 Waddington S. N., Tam F. W. K., Cook H. T. and Cattell V. (1998) Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells. Am. J. Physiol. 274: F473-F480
113. 113 Que L. G., Kantrow S. P., Jenkinson C. P., Piantadosi C. A. and Huang Y. C. (1998) Induction of arginase isoforms in the lung during hyperoxia. Am. J. Physiol. 275: L96-L102
114. 114 Albina J. E., Henry W. L., Mastrofrancesco B., Martin B. A. and Reichner J. S. (1995) Macrophage activation by culture in an anoxic environment. J. Immunol. 155: 4391-4396
115. 115 Modolell M, Corraliza I, M., Link P., Soler G. and Eichmann K. (1995) Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by Th1 and Th2 cytokines. Eur. J. Immunol. 25: 1101-1104
116. 116 Bogdan C., Vodovotz Y., Paik J., Xic Q. W. and Nathan C. (1994) Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukoc. Biol. 55: 227-233
117. 117 Oswald I. P., Wynn T. A., Sher A. and James S. L. (1992) Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for Interferon gamma-induced activation. Proc. Natl. Acad. Sci. USA 89: 8676-8680
118. + T cells correlates with Th1/Th2 phenotype. J. Immunol. 160: 5347-5354
119. 119 Gotoh T., Chowdhury S., Takiguchi M. and Mori M. (1997) The glucocorticoid-responsive gene cascade: activation of the rat arginase gene through induction of C. EBPbeta. J. Biol. Chem. 272: 3694-3698
120. 120 Grofte T., Jensen D. S., Gronback H., Wolthers T., Jensen S. A., Tygstrup N. et al. (1998) Effects of growth hormone on steroid-induced increase in ability of urea synthesis and urea enzyme mRNA levels. Am. J. Physiol. 275: E79-E86
121. 121 Boulard V., Havouis R., Fouqueray B., Philippe C., Moulinoux J. P. and Baud L. (1995) Transforming growth factor-beta stimulates arginase activity in macrophages: implication for the regulation of macrophage cytotoxicily. J. Immunol. 155: 2077-2084
122. G-Hydroxy-L-arginine and nitric oxide inhibit caco-2 tumor cell proliferation by distinct mechanisms. Am. J. Physiol. 275: R1256-R1264
123. 123 Esch F., Lin K. L, Hills A., Zaman K., Baraban J. M., Chatterjee S. et al. (1998) Purification of a multipotent antidealh activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis. J. Neurosci. 18: 4083-4095